Manint Usawachintachit
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Manint Usawachintachit has a total of 191 co-authors. Here are the top co-authors by number of shared publications:
- Thomas Chi
Department of Urology, University of Alabama at Birmingham, Birmingham, USA
22 shared publications Thomas Chi
Department of Urology, University of California San Francisco, San Francisco, CA
19 shared publicationsKazumi Taguchi
Department of Urology, University of California, San Francisco, California, USA; Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
16 shared publicationsDavid T. Tzou
Department of Urology, University of California, San Francisco, California, USA
15 shared publicationsMarshall L. Stoller
Department of Urology, University of California, San Francisco, California, USA
10 shared publicationsMarshall Stoller
University of California San Francisco, Urology, San Francisco, CA
10 shared publications
Latest Publications
- Open Access
- 17 June 2026
- Published by Maad Rayan Publishing Company in Journal of lasers in medical sciences
- Vol. 17, e48963
A comparative study of thulium fiber laser and holmium:YAG laser for prostate enucleation: a systematic review and meta-analysis
Introduction: Laser enucleation has become a preferred surgical treatment for benign prostatic hyperplasia (BPH), especially for large prostates and patients unable to discontinue anticoagulation. This systematic review and meta-analysis compared the efficacy and safety of Thulium Fiber Laser Enucleation of the Prostate (ThuFLEP) and Holmium Laser Enucleation of the Prostate (HoLEP). Methods: We searched PubMed, Scopus, Embase, and the Cochrane Library for studies published up to February 2025. We included randomized controlled trials and observational studies comparing ThuFLEP and HoLEP in adult males with BPH. Outcomes included symptom scores (IPSS), urinary flow (Qmax), quality of life (QoL), post-void residual (PVR), enucleation time, operative time, enucleation efficiency, and complications. Risk of bias was assessed using the Cochrane RoB 2.0 tool for RCTs and the Newcastle-Ottawa Scale for cohort studies. Data were synthesized using random-effects meta-analysis models. Results: Eleven studies were included. IPSS, QoL, PVR, total operative time, and complications showed no significant differences between groups. HoLEP showed a significantly greater Qmax improvement at 3 months (mean difference -1.25 mL/s; 95% CI -1.847 to -0.653) and shorter enucleation time (mean difference 7.654 min; 95% CI 0.362 to 14.947), though the clinical relevance was limited. No significant differences were observed in enucleation efficiency or urinary incontinence rates. Study limitations included heterogeneity in laser settings and surgical technique, limited RCTs, and a lack of long-term follow-up. Conclusion: ThuFLEP and HoLEP are comparable in efficacy and safety for prostate enucleation in BPH patients. While HoLEP showed modest advantages in specific operative metrics, the clinical impact appears minimal. TFL represents a viable alternative in the surgical management of BPH.
- 17 June 2026
- Published by Maad Rayan Publishing Company in Journal of lasers in medical sciences
- Vol. 17, e48963
Open AccessA comparative study of thulium fiber laser and holmium:YAG laser for prostate enucleation: a systematic review and meta-analysis
Introduction: Laser enucleation has become a preferred surgical treatment for benign prostatic hyperplasia (BPH), especially for large prostates and patients unable to discontinue anticoagulation. This systematic review and meta-analysis compared the efficacy and safety of Thulium Fiber Laser Enucleation of the Prostate (ThuFLEP) and Holmium Laser Enucleation of the Prostate (HoLEP). Methods: We searched PubMed, Scopus, Embase, and the Cochrane Library for studies published up to February 2025. We included randomized controlled trials and observational studies comparing ThuFLEP and HoLEP in adult males with BPH. Outcomes included symptom scores (IPSS), urinary flow (Qmax), quality of life (QoL), post-void residual (PVR), enucleation time, operative time, enucleation efficiency, and complications. Risk of bias was assessed using the Cochrane RoB 2.0 tool for RCTs and the Newcastle-Ottawa Scale for cohort studies. Data were synthesized using random-effects meta-analysis models. Results: Eleven studies were included. IPSS, QoL, PVR, total operative time, and complications showed no significant differences between groups. HoLEP showed a significantly greater Qmax improvement at 3 months (mean difference -1.25 mL/s; 95% CI -1.847 to -0.653) and shorter enucleation time (mean difference 7.654 min; 95% CI 0.362 to 14.947), though the clinical relevance was limited. No significant differences were observed in enucleation efficiency or urinary incontinence rates. Study limitations included heterogeneity in laser settings and surgical technique, limited RCTs, and a lack of long-term follow-up. Conclusion: ThuFLEP and HoLEP are comparable in efficacy and safety for prostate enucleation in BPH patients. While HoLEP showed modest advantages in specific operative metrics, the clinical impact appears minimal. TFL represents a viable alternative in the surgical management of BPH.
- Open Access
- 12 January 2026
- Published by Korean Association of Anatomists in Anatomy & Cell Biology
- Vol. 59 (1) , 21-29
Morphology and morphometry of the fundiform and suspensory ligaments of the penis in Thai population
Pawarit Wipaswatcharayotin, Sithiporn Agthong, Preeyanan Sae-lim, Manint Usawachintachit, Kawintharat Harirugsakul, Soravich Lohasomboon, Kavirach Tantiwongse, Vilai Chentanez. Anat Cell Biol -0001;0:. https://doi.org/10.5115/acb.25.236
- 12 January 2026
- Published by Korean Association of Anatomists in Anatomy & Cell Biology
- Vol. 59 (1) , 21-29
Open AccessMorphology and morphometry of the fundiform and suspensory ligaments of the penis in Thai population
Pawarit Wipaswatcharayotin, Sithiporn Agthong, Preeyanan Sae-lim, Manint Usawachintachit, Kawintharat Harirugsakul, Soravich Lohasomboon, Kavirach Tantiwongse, Vilai Chentanez. Anat Cell Biol -0001;0:. https://doi.org/10.5115/acb.25.236
- Open Access
- 10 April 2025
- Published by Springer Nature in Research Square
Novel Predictive Factors Scoring Model for Persistent Hypertension after Adrenalectomy in Patients with Primary Aldosteronism
Primary aldosteronism (PA) is the most common endocrinologic hypertension, affecting 3.9–15% of hypertensive patients. While unilateral PA is potentially curable through adrenalectomy, a significant proportion of patients experience persistent hypertension despite successful surgery. This study developed and validated a novel predictive scoring model for persistent hypertension following adrenalectomy based on 363 patients from a 25-year single-center experience. Persistent hypertension occurred in 59.5% of patients postoperatively. Multivariable analysis identified five independent predictors: age ≥ 50 years, dyslipidemia, BMI ≥ 25 kg/m², use of ≥ 3 antihypertensive medications, and hypertension duration ≥ 5 years. The model demonstrated excellent discriminative ability with area under the curve of 0.81 in internal validation and 0.72 in external validation. Patients were stratified into low-risk (0–1), intermediate-risk (2–3), and high-risk (4–5) groups, with persistent hypertension rates of 23.5%, 72.1%, and 90.6%, respectively. This practical scoring system enables improved preoperative counseling and individualized management planning using readily available clinical parameters.
- 10 April 2025
- Published by Springer Nature in Research Square
Open AccessNovel Predictive Factors Scoring Model for Persistent Hypertension after Adrenalectomy in Patients with Primary Aldosteronism
Primary aldosteronism (PA) is the most common endocrinologic hypertension, affecting 3.9–15% of hypertensive patients. While unilateral PA is potentially curable through adrenalectomy, a significant proportion of patients experience persistent hypertension despite successful surgery. This study developed and validated a novel predictive scoring model for persistent hypertension following adrenalectomy based on 363 patients from a 25-year single-center experience. Persistent hypertension occurred in 59.5% of patients postoperatively. Multivariable analysis identified five independent predictors: age ≥ 50 years, dyslipidemia, BMI ≥ 25 kg/m², use of ≥ 3 antihypertensive medications, and hypertension duration ≥ 5 years. The model demonstrated excellent discriminative ability with area under the curve of 0.81 in internal validation and 0.72 in external validation. Patients were stratified into low-risk (0–1), intermediate-risk (2–3), and high-risk (4–5) groups, with persistent hypertension rates of 23.5%, 72.1%, and 90.6%, respectively. This practical scoring system enables improved preoperative counseling and individualized management planning using readily available clinical parameters.
- Open Access
- 1 November 2020
- Published by Elsevier in Urology Case Reports
- Vol. 33
Leiomyosarcoma of the renal pelvis diagnosed by percutaneous endoscopic resection
- 1 November 2020
- Published by Elsevier in Urology Case Reports
- Vol. 33
Open AccessLeiomyosarcoma of the renal pelvis diagnosed by percutaneous endoscopic resection
- 1 May 2020
- Published by Elsevier in Kidney International
- Vol. 97 (5) , 1042-1056
Fatty acid–binding protein 4 downregulation drives calcification in the development of kidney stone disease
- 1 May 2020
- Published by Elsevier in Kidney International
- Vol. 97 (5) , 1042-1056
Fatty acid–binding protein 4 downregulation drives calcification in the development of kidney stone disease
- Open Access
- 8 July 2019
- Published by Wiley in IJU Case Reports
- Vol. 2 (5) , 260
Editorial Comment to Hemothorax during miniaturized endoscopic combined intrarenal surgery under ureteroscope‐assisted ultrasound‐guided access
- 8 July 2019
- Published by Wiley in IJU Case Reports
- Vol. 2 (5) , 260
Open AccessEditorial Comment to Hemothorax during miniaturized endoscopic combined intrarenal surgery under ureteroscope‐assisted ultrasound‐guided access
- 1 July 2019
- Published by SAGE Publications in Journal of Endourology
- Vol. 33 (7) , 619-624
Computed Tomography Radiation Exposure Among Referred Kidney Stone Patients: Results from the Registry for Stones of the Kidney and Ureter
Purpose: Kidney stone patients routinely have CT scans during diagnostic work-up before being referred to a tertiary center. How often these patients exceed the recommended dose limits for occupational radiation exposure of >100 mSv for 5 years and >50 mSv in a single year from CT alone remains unknown. This study aimed to quantify radiation doses from CTs received by stone patients before their evaluation at a tertiary care stone clinic. Methods: From November 2015 to March 2017, consecutive new patients enrolled into the Registry for Stones of the Kidney and Ureter (ReSKU™) had the dose-length product of every available CT abdomen/pelvis within 5 years of their initial visit recorded, allowing for an effective dose (EDose) calculation. Multivariate logistic regression analysis identified factors associated with exceeding recommended dose limits. Models were created to test radiation reducing effects of low-dose and phase-reduction CT protocols. Results: Of 343 noncontrast CTs performed, only 29 (8%) were low-dose CTs (calculated EDose 20 mSv and >50 mSv/year, respectively. Increased body mass index, number of scans, and multiphase scans were associated with exceeding exposure thresholds ( p < 0.01). The implementation of a low-dose CT protocol decreased the estimated number of scans contributing to overexposure by >50%. Conclusions: Stone patients referred to a tertiary stone center may receive excessive radiation from CT scans alone. Unnecessary phases and underutilization of low-dose CT protocols continue to take place. Enacting new approaches to CT protocols may spare stone patients from exceeding recommended dose limits.
- 1 July 2019
- Published by SAGE Publications in Journal of Endourology
- Vol. 33 (7) , 619-624
Computed Tomography Radiation Exposure Among Referred Kidney Stone Patients: Results from the Registry for Stones of the Kidney and Ureter
Purpose: Kidney stone patients routinely have CT scans during diagnostic work-up before being referred to a tertiary center. How often these patients exceed the recommended dose limits for occupational radiation exposure of >100 mSv for 5 years and >50 mSv in a single year from CT alone remains unknown. This study aimed to quantify radiation doses from CTs received by stone patients before their evaluation at a tertiary care stone clinic. Methods: From November 2015 to March 2017, consecutive new patients enrolled into the Registry for Stones of the Kidney and Ureter (ReSKU™) had the dose-length product of every available CT abdomen/pelvis within 5 years of their initial visit recorded, allowing for an effective dose (EDose) calculation. Multivariate logistic regression analysis identified factors associated with exceeding recommended dose limits. Models were created to test radiation reducing effects of low-dose and phase-reduction CT protocols. Results: Of 343 noncontrast CTs performed, only 29 (8%) were low-dose CTs (calculated EDose 20 mSv and >50 mSv/year, respectively. Increased body mass index, number of scans, and multiphase scans were associated with exceeding exposure thresholds ( p < 0.01). The implementation of a low-dose CT protocol decreased the estimated number of scans contributing to overexposure by >50%. Conclusions: Stone patients referred to a tertiary stone center may receive excessive radiation from CT scans alone. Unnecessary phases and underutilization of low-dose CT protocols continue to take place. Enacting new approaches to CT protocols may spare stone patients from exceeding recommended dose limits.
- 1 July 2019
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 202 (1) , 119-124
Low Income and Nonwhite Race are Strongly Associated with Worse Quality of Life in Patients with Nephrolithiasis
Purpose:Kidney stones are a source of significant morbidity and have been shown to negatively impact health-related quality of life (HRQoL). We aimed to understand the association between HRQoL, socioeconomic status (SES), and race among patients with kidney stones.Materials and Methods:Kidney stone patients at 11 stone centers across the U.S. completed the Wisconsin Stone Quality of Life questionnaire (WISQOL). Patient ZIP codes were used to estimate household income. A mixed-effects regression model was used for analysis, with ZIP code as the random intercept.Results:A total of 2,057 stone formers completed WISQOL. Lower income was independently associated with significantly lower HRQoL (β = 0.372, p = 0.014), as were non-White race (β = -0.299, p = 0.001), unemployed work status (β = -0.291, p = 0.008), female gender (β = -0.204, p < 0.001), body mass index (BMI) over 40 (β = -0.380, p < 0.001), five or more medical comorbidities (β = -0.354, p = 0.001), severe recurrent stone formation (β = -0.146, p ...
- 1 July 2019
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 202 (1) , 119-124
Low Income and Nonwhite Race are Strongly Associated with Worse Quality of Life in Patients with Nephrolithiasis
Purpose:Kidney stones are a source of significant morbidity and have been shown to negatively impact health-related quality of life (HRQoL). We aimed to understand the association between HRQoL, socioeconomic status (SES), and race among patients with kidney stones.Materials and Methods:Kidney stone patients at 11 stone centers across the U.S. completed the Wisconsin Stone Quality of Life questionnaire (WISQOL). Patient ZIP codes were used to estimate household income. A mixed-effects regression model was used for analysis, with ZIP code as the random intercept.Results:A total of 2,057 stone formers completed WISQOL. Lower income was independently associated with significantly lower HRQoL (β = 0.372, p = 0.014), as were non-White race (β = -0.299, p = 0.001), unemployed work status (β = -0.291, p = 0.008), female gender (β = -0.204, p < 0.001), body mass index (BMI) over 40 (β = -0.380, p < 0.001), five or more medical comorbidities (β = -0.354, p = 0.001), severe recurrent stone formation (β = -0.146, p ...